Actively Recruiting
Randomized Study Comparing Cadonilimab Plus Chemotherapy to Chemotherapy With or Without Nivolumab in First-Line Treatment of HER2-Negative Advanced Gastric or Gastroesophageal Junction Cancer
Led by Akeso · Updated on 2026-09-29
900
Participants Needed
25
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a phase 3 randomized, double-blind study to compare the overall survival of participants with HER2-negative, previously untreated, unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma. The study evaluates cadonilimab combined with chemotherapy against chemotherapy with or without nivolumab in this patient group. This trial aims to understand how these treatments affect survival in participants with this advanced form of cancer. Participants are assigned to one of two treatment groups one receiving cadonilimab or placebo combined with oxaliplatin and capecitabine CAPOX, and the other receiving CAPOX with or without nivolumab. The treatments involve intravenous administration as part of a first-line therapy. The study is multi-regional and double-blinded to compare these combinations effectively over the treatment period. During the study, participants will undergo regular assessments including measuring tumor response and disease progression up to approximately 8 months, and safety evaluations up to 18 months. Overall survival is tracked for about 14 months. Laboratory tests and evaluations of organ function are performed before treatment. Participants are monitored closely for side effects and treatment response throughout the study, which may last several months depending on individual progress.
CONDITIONS
Brief Title
Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma
Research Team
Z
Zhifang Yao, MD
Y
Yelena Janjigian, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here